These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7905102)

  • 1. Pathogenesis of multiple sclerosis.
    Ffrench-Constant C
    Lancet; 1994 Jan; 343(8892):271-5. PubMed ID: 7905102
    [No Abstract]   [Full Text] [Related]  

  • 2. Virus-specific cytotoxic T cells in multiple sclerosis.
    McFarland HF; Goodman A; Jacobson S
    Ann N Y Acad Sci; 1988; 532():273-9. PubMed ID: 3263072
    [No Abstract]   [Full Text] [Related]  

  • 3. Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells.
    Mattapallil MJ; Silver PB; Mattapallil JJ; Horai R; Karabekian Z; McDowell JH; Chan CC; James EA; Kwok WW; Sen HN; Nussenblatt RB; David CS; Caspi RR
    J Immunol; 2011 Aug; 187(4):1977-85. PubMed ID: 21765017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the immunological pathogenesis of the seronegative autoimmune diseases].
    Shinomiya N
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Aug; 25(4):302-9. PubMed ID: 16583737
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-barr virus: environmental trigger of multiple sclerosis?
    Lünemann JD; Kamradt T; Martin R; Münz C
    J Virol; 2007 Jul; 81(13):6777-84. PubMed ID: 17459939
    [No Abstract]   [Full Text] [Related]  

  • 6. Humanized animal models for autoimmune diseases.
    Gregersen JW; Holmes S; Fugger L
    Tissue Antigens; 2004 May; 63(5):383-94. PubMed ID: 15104670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA transgenic mice as humanized mouse models of disease and immunity.
    Taneja V; David CS
    J Clin Invest; 1998 Mar; 101(5):921-6. PubMed ID: 9486959
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis.
    Greer JM; Csurhes PA; Muller DM; Pender MP
    J Immunol; 2008 May; 180(9):6402-10. PubMed ID: 18424764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA transgenic mice as models of human autoimmune diseases.
    Das P; Abraham R; David C
    Rev Immunogenet; 2000; 2(1):105-14. PubMed ID: 11324683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of multiple sclerosis--how could disease-associated HLA-types contribute to pathogenesis?
    Martin R
    J Neural Transm Suppl; 1997; 49():177-94. PubMed ID: 9266427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DQ associations with autoimmune disease.
    Altmann DM
    Autoimmunity; 1992; 14(1):79-83. PubMed ID: 1299350
    [No Abstract]   [Full Text] [Related]  

  • 12. Dengue virus-specific, human CD4+ cytotoxic T lymphocytes generated in short-term culture.
    Zivny J; Kurane I; Tacket CO; Edelman R; Ennis FA
    Viral Immunol; 1993; 6(2):143-51. PubMed ID: 8105794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4(+) T-cell epitope in human interferon-beta.
    Stickler M; Valdes AM; Gebel W; Razo OJ; Faravashi N; Chin R; Rochanayon N; Harding FA
    Genes Immun; 2004 Jan; 5(1):1-7. PubMed ID: 14735143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory B Cells Activate Brain-Homing, Autoreactive CD4
    Jelcic I; Al Nimer F; Wang J; Lentsch V; Planas R; Jelcic I; Madjovski A; Ruhrmann S; Faigle W; Frauenknecht K; Pinilla C; Santos R; Hammer C; Ortiz Y; Opitz L; Grönlund H; Rogler G; Boyman O; Reynolds R; Lutterotti A; Khademi M; Olsson T; Piehl F; Sospedra M; Martin R
    Cell; 2018 Sep; 175(1):85-100.e23. PubMed ID: 30173916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DQB1 alleles may influence the surface expression of DQ molecules in lymphomononuclear cells of type 1 diabetes mellitus patients.
    Fernandes AP; Foss MC; Donadi EA
    Scand J Immunol; 2004 Mar; 59(3):305-9. PubMed ID: 15030582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: immune mechanism and update on current therapies.
    Bansil S; Cook SD; Rohowsky-Kochan C
    Ann Neurol; 1995 May; 37 Suppl 1():S87-101. PubMed ID: 8968220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunogenetic heterogeneity in multiple sclerosis.
    Hillert J; Grönning M; Nyland H; Link H; Olerup O
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):887-90. PubMed ID: 1359021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could HLA-DRB1 be the protective locus in rheumatoid arthritis?
    Zanelli E; Gonzalez-Gay MA; David CS
    Immunol Today; 1995 Jun; 16(6):274-8. PubMed ID: 7544977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of multiple sclerosis.
    Hoppenbrouwers IA; Hintzen RQ
    Biochim Biophys Acta; 2011 Feb; 1812(2):194-201. PubMed ID: 20933079
    [No Abstract]   [Full Text] [Related]  

  • 20. A vulnerability locus to multiple sclerosis maps to 7p15 in a region syntenic to an EAE locus in the rat.
    Coppin H; Ribouchon MT; Fontaine B; Edan G; Clanet M; Roth MP;
    Genes Immun; 2004 Jan; 5(1):72-5. PubMed ID: 14735153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.